Generating Cell Type-Specific Protein Signatures from Non-symptomatic and Diseased Tissues

Area of Science:

• Neuroscience
• Proteomics
• Biochemistry

Background:

• Alzheimer's disease (AD) research often lacks cell type-specific protein data.
• Existing human AD proteomics studies show broad trends but limited cell-specific insights.
• Cellular heterogeneity in brain tissue complicates the study of neurodegenerative diseases.

Purpose of the Study:

• To develop and validate a novel technique for generating cell type-specific proteomic signatures.
• To apply this method to characterize proteomic differences in neural cell types from Alzheimer's disease and non-symptomatic brains.
• To address the limitations of current methods in resolving protein expression within specific cell populations.

Main Methods:

• Adaptation of the Formaldehyde-fixed Intracellular Target-Sorted Antigen Retrieval (FITSAR) method for proteomic analysis.
• Application of FITSAR to isolate and analyze neural cell types (neurons and astrocytes) from post-mortem human brain tissue.
• Comparative proteomic profiling of Alzheimer's disease (AD) and age-matched non-symptomatic (NS) brain samples.

Main Results:

• Successful generation of enriched neuron and astrocyte proteomic profiles from human brain donors.
• Demonstration of the feasibility of the FITSAR technique for evaluating cell-type specific hypotheses in AD.
• Identification of cell-type specific protein signatures relevant to Alzheimer's disease.

Conclusions:

• The FITSAR method provides an accessible platform for determining protein presence in specific cell types.
• This technique is crucial for resolving complex biological systems affected by cellular heterogeneity.
• The findings underscore the need for protein-compatible techniques to advance neurodegenerative disease research.